Santen Pharmaceutical Co (JP:4536) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Santen Pharmaceutical Co., Ltd. has announced the repurchase of 2,855,300 of its common shares, totaling 4,981,925,500 yen, between July 1 and July 31, 2024. This buyback is part of a larger repurchase program approved by the board on May 9, 2024, which allows for a maximum of 21,110,000 shares to be bought back. To date, the company has repurchased 9,973,000 shares for 16,342,935,400 yen under this program.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
